Autoimmune Diseases and Cannabis Part 1 – Multiple Sclerosis
It is estimated that roughly 7% of the US population lives with an autoimmune disease. In the first installment of this 10-part series, we will take an in-depth look at utilizing cannabinoid therapies for one of the most common autoimmune diseases, Multiple Sclerosis. Multiple Sclerosis, or MS for short, affects an estimated 2.3 million individuals around the globe. This disease is characterized by numbness and tingling in the face and extremities, pain, problems with concentration, weakness, imbalance, and other symptoms. While some Multiple Sclerosis patients are able to find consistent relief through modern therapies, others are not. This leads many patients to looking for holistic options, and thankfully many of them are finding much success within cannabinoid therapies. Research to date shows substantial hope for MS patients looking to utilize cannabinoid therapies. With inflammation being at the root of many pain-related diseases, including MS, it is natural to expect cannabinoid therapies, especially those that include THC, to help provide relief. This is because THC has repetitively been shown to offer significant anti-inflammatory properties. However, THC isn’t the only thing within cannabis that provides therapeutic value for those with Multiple Sclerosis. Check out this article to learn more about how cannabis may help Multiple Sclerosis patients.